MTS Medication Technologies, Inc. (NASDAQ: MTSI) entered into a definitive merger agreement to be acquired for $5.75 per share in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE